Informed Consent: A Clinical Trials Perspective

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Oncology Nursing Society Country of Publication: United States NLM ID: 7809033 Publication Model: Print Cited Medium: Internet ISSN: 1538-0688 (Electronic) Linking ISSN: 0190535X NLM ISO Abbreviation: Oncol Nurs Forum Subsets: MEDLINE
    • Publication Information:
      Publication: Pittsburgh, PA : Oncology Nursing Society
      Original Publication: New York, Oncology Nursing Society.
    • Subject Terms:
    • Abstract:
      The primary goal of the thousands of registered trials in cancer research is to extend survival. With evaluation of efficacy, safety, and tolerability, healthcare providers must ensure that the principles described in the Belmont Report are upheld and that patients are truly informed when signing a consent form. In this article, two cases are highlighted, and reasons for participating in clinical trials are discussed. Challenges, such as healthcare literacy, patients' dedication to their healthcare providers, and choosing between multiple trials, are also explored.
    • References:
      BMC Cancer. 2016 Jul 07;16:412. (PMID: 27389564)
      N Engl J Med. 2011 Aug 25;365(8):725-33. (PMID: 21830940)
      Nat Rev Genet. 2000 Nov;1(2):91-9. (PMID: 11253666)
      Clin Epidemiol. 2016 Jun 11;8:195-200. (PMID: 27354827)
      Am J Law Med. 2010;36(2-3):295-325. (PMID: 20726398)
      J Am Coll Dent. 2014 Summer;81(3):4-13. (PMID: 25951677)
    • Grant Information:
      P30 CA008748 United States CA NCI NIH HHS
    • Contributed Indexing:
      Keywords: biology of cancer; ethics; genetics; nursing research
    • Publication Date:
      Date Created: 20161022 Date Completed: 20171016 Latest Revision: 20240327
    • Publication Date:
      20240327
    • Accession Number:
      PMC5637387
    • Accession Number:
      10.1188/16.ONF.694-696
    • Accession Number:
      27768140